March 24, 2008 -- China Medical Technologies, Inc. (NSDQ: CMED) was awarded the Conformité Européenne Mark (CE Mark) for two semi-automatic ECLIA analyzers and 15 reagents, including reagents for thyroid disorders, diabetes and tumor markers. The CE Mark indicates the product meets the provisions of the In-Vitro Diagnostic Directive (IVDD) of the European Union. More details...
